Observed and predicted risk of breast cancer death in randomized trials on breast cancer screening

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Autier, Philippe ^a   Boniol, Mathieu ^a   Smans, Michel ^a   Sullivan, Richard ^b   Boyle, Peter ^a  

^a INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SIGMOIDOSCOPY; SWEDEN; UNITED KINGDOM; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; MASS SCREENING; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; SURVIVAL RATE;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84964691639     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154113     Document Type: Article

References (44)

1. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction inmortality from breast cancer aftermass screening withmammography. Randomised trial fromthe Breast Cancer ScreeningWorking Group of the Swedish National Board of Health andWelfare. Lancet. 1985; 1(8433):829-32. PMID: 2858707
2. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr. 1985; 67:65-74. PMID: 4047153
3. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002; 359 (9310):909-19. PMID: 11918907
4. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002; 137(5 Part 1):305-12. PMID: 12204013
5. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst. 2000; 92(18):1490-9. PMID: 10995804
6. Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and Harms of Breast Cancer Screening: A Systematic Review. Jama. 2015; 314(15):1615-34. doi: 10.1001/jama. 2015.13183 PMID: 26501537
7. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011; 343:d4411. doi: 10.1136/bmj.d4411 PMID: 21798968
8. Jorgensen KJ, Zahl PH, Gotzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. Bmj. 2010; 340:c1241. doi: 10.1136/bmj.c1241 PMID: 20332505
9. Broeders MJ, Peer PG, Straatman H, Beex LV, Hendriks JH, Holland R, et al. Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969-1997. Int J Cancer. 2001; 92(2):303-8. PMID: 11291061
10. Autier P, Koechlin A, Smans M, Vatten L, Boniol M. Mammography screening and breast cancer mortality in Sweden. J Natl Cancer Inst. 2012; 104(14):1080-93. doi: 10.1093/jnci/djs272 PMID: 22811439
11. Harding C, Pompei F, Burmistrov D, Welch HG, Abebe R, Wilson R. Breast Cancer Screening, Incidence, and Mortality Across US Counties. JAMA Intern Med. 2015.
12. Bleyer A, Baines C, Miller AB. Impact of Screening Mammography on Breast Cancer Mortality. Int J Cancer. 2015.
13. Ait Ouakrim D, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, et al. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ. 2015; 351:h4970. doi: 10.1136/bmj.h4970 PMID: 26442928
14. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987; 1(8544):1247-9. PMID: 2884378
15. Miller AB, Lindsay J, Hill GB. Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer. 1976; 17(5):602-12. PMID: 1270176
16. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012; 366(25):2345-57. doi: 10.1056/NEJMoa1114635 PMID: 22612596
17. International Agency for Research on Cancer. Breast Cancer Screening: IARCPress; 2002.
18. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137(5 Part 1):347-60. PMID: 12204020
19. Gotzsche PC, Jorgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013; 6:Cd001877. doi: 10.1002/14651858.CD001877.pub5 PMID: 23737396
20. Morrison AS, Brisson J, Khalid N. Breast cancer incidence and mortality in the breast cancer detection demonstration project [published errtum appears in J Natl Cancer Inst 1989 Oct 4;81(19):1513]. J Natl Cancer Inst. 1988; 80(19):1540-7. PMID: 3193469
21. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 1995; 75(10):2507-17. PMID: 7736395
22. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992; 30(1):187-210. PMID: 1732926
23. Tabar L, Fagerberg G, Day NE, Duffy SW, Kitchin RM. Breast cancer treatment and natural history: new insights from results of screening. Lancet. 1992; 339(8790):412-4. PMID: 1346670
24. Duffy SW, Tabar L, Fagerberg G, Gad A, Grontoft O, South MC, et al. Breast screening, prognostic factors and survival - results from the Swedish two county study. Br J Cancer. 1991; 64(6):1133-8. PMID: 1764377
25. Moss S, Waller M, Anderson TJ, Cuckle H, Trial Management G. Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. Br J Cancer. 2005; 92(5):955-60. PMID: 15726103
26. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 1977; 39(6 Suppl):2772-82. PMID: 326378
27. Morrison AS. Intermediate determinants of mortality in the evaluation of screening. Int J Epidemiol. 1991; 20(3):642-50. PMID: 1955248
28. Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Bjorneld L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res. 2005; 7(6):258-65. PMID: 16457701
29. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006; 368(9552):2053-60. PMID: 17161727
30. Anderson TJ, Waller M, Ellis IO, Bobrow L, Moss S. Influence of annual mammography from age 40 on breast cancer pathology. Human Pathology. 2004; 35(10):1252-9. PMID: 15492993
31. Birnbaum J, Gadi V.K., Markowitz E., Etzioni R. The impact of treatment advances on the mortality results of breast cancer screening trials: A microsimulation model. Annals of Internal Medicine. 2015.
32. Autier P, Hery C, Haukka J, Boniol M, Byrnes G. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol. 2009; 27(35):5919-23. doi: 10.1200/JCO.2009.22.7041 PMID: 19884547
33. Shapiro S, Venet W, Strax P, Venet L. Current results of the breast cancer screening randomized trial: the health insurance plan (HIP) of greater New York study. Screening for breast cancer. Toronto: Huber Toronto; 1987. p. 3-15.
34. Miller AB. Screening for breast cancer with mammography. Lancet. 2001; 358(9299):2164; author reply 7-8.
35. Andersson I, Aspegren K, Janzon L, Landberg T, LindholmK, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 1988; 297(6654):943-8. PMID: 3142562
36. Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, et al. The Gothenburg Breast Screening Trial. Cancer. 2003; 97(10):2387-96. PMID: 12733136
37. Biesheuvel C, Czene K, Orgeas CC, Hall P. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value? Cancer Epidemiol. 2011; 35(6):545-50. doi: 10.1016/j.canep.2011.02.008 PMID: 21470933
38. Mook S, Van 't Veer LJ, Rutgers EJ, Ravdin PM, van de Velde AO, van Leeuwen FE, et al. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst. 2011; 103(7):585-97. doi: 10.1093/jnci/djr043 PMID: 21350218
39. Peer PG, Holland R, Hendriks JH, Mravunac M, Verbeek AL. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness. J Natl Cancer Inst. 1994; 86(6):436-41. PMID: 8120918
40. Fink R, Shapiro S, Lewison J. The Reluctant Participant in a Breast Cancer Screening Program. Rep Pub Health. 1968; 83(6):479-90.
41. Nystrom L. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993; 341.
42. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. The Lancet. 2002; 359 (9310):909-19.
43. Boniol M, Autier P, Gandini S. Melanoma mortality following skin cancer screening in Germany. BMJ Open. 2015; 5(9):e008158. doi: 10.1136/bmjopen-2015-008158 PMID: 26373399
44. Stang A, Jockel KH. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany. Cancer. 2015.